Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human CLCN7 Protein, N-His

Catalog #:   YHE87201 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P51798
Protein length: Phe597-Thr805
Overview

Catalog No.

YHE87201

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Phe597-Thr805

Predicted molecular weight

26.25 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P51798

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Chloride channel 7 alpha subunit, CLCN7, ClC-7, Chloride channel protein 7, H(+)/Cl(-) exchange transporter 7

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Human CLCN7 protein
References

[Clinical and genetic characteristics of osteopetrosis in children]., PMID:40462430

Identification of a novel mutation in the CLCN7 gene in pediatric osteopetrosis: case report., PMID:40276109

SUGAR-seq reveals the transcriptome and N-linked glycosylation landscape of mononuclear phagocytes at single-cell resolution in a mouse model of autosomal dominant osteopetrosis type 2., PMID:40165215

Sorting nexin 10 regulates lysosomal ionic homeostasis via ClC-7 by controlling PI(3,5)P2., PMID:40138451

Metabolomics study of osteopetrosis caused by CLCN7 mutation reveals novel pathway and potential biomarkers., PMID:40018371

A novel frameshift variant leads to familial osteopetrosis with variable phenotypes in a Chinese Han consanguineous family., PMID:39994654

Development and evaluation of siRNA-mediated gene silencing strategies for ADO2 therapy utilizing iPSCs model and DMPC-SPIONs delivery system., PMID:39934917

A comprehensive report of the clinical and mutational profiles of 30 Iranian malignant infantile osteopetrosis patients., PMID:39875016

Downregulation of chloride voltage-gated channel 7 contributes to hyperalgesia following spared nerve injury., PMID:39276933

Multisystem disorder associated with a pathogenic variant in CLCN7 in the absence of osteopetrosis., PMID:39056574

Abnormal dental follicle cells: A crucial determinant in tooth eruption disorders (Review)., PMID:39027997

Gain-of-function variants in CLCN7 cause hypopigmentation and lysosomal storage disease., PMID:38838776

Effect of Allele-Specific Clcn7G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background., PMID:38733412

Osteopetrosis and related osteoclast disorders in adults: A review and knowledge gaps On behalf of the European calcified tissue society and ERN BOND., PMID:38593953

Role of gene interactions in the pathophysiology of skeletal dysplasias: A case report in Colombia., PMID:38494246

The PDE4 Inhibitors Roflumilast and Rolipram Rescue ADO2 Osteoclast Resorption Dysfunction., PMID:38483547

Galectin-8 modulates human osteoclast activity partly through isoform-specific interactions., PMID:38395460

Effect of parental adverse childhood experiences on intergenerational DNA methylation signatures from peripheral blood mononuclear cells and buccal mucosa., PMID:38342906

Effect of Roflumilast, a Selective PDE4 Inhibitor, on Bone Phenotypes in ADO2 Mice., PMID:38300304

The Cl- transporter ClC-7 is essential for phagocytic clearance by microglia., PMID:38294065

Osteopetrosis complicated by multilevel spondylolysis., PMID:38292800

Autosomal Dominant Osteopetrosis (ADO) Caused by a Missense Variant in the TCIRG1 Gene., PMID:38261998

Impaired Autophagic Clearance with a Gain-of-Function Variant of the Lysosomal Cl-/H+ Exchanger ClC-7., PMID:38136669

[Analysis of clinical presentation and genetic characteristics of malignant infantile osteopetrosis]., PMID:37899344

Genotype-phenotype analysis of selective failure of tooth eruption-A systematic review., PMID:37448157

CRISPR/Cas9-Mediated Gene Correction in Osteopetrosis Patient-Derived iPSCs., PMID:37395026

Molecular Mechanisms of Craniofacial and Dental Abnormalities in Osteopetrosis., PMID:37373559

The chloride antiporter CLCN7 is a modifier of lysosome dysfunction in FIG4 and VAC14 mutants., PMID:37363915

Autosomal dominant osteopetrosis., PMID:36863500

CLCN7, a gene shared by autosomal recessive and autosomal dominant osteopetrosis., PMID:36513280

Hematopoietic stem cell transplantation, a curative approach in infantile osteopetrosis., PMID:36470372

Haemodynamic stroke in a rare adult presentation of osteopetrosis., PMID:36162965

Identification of key genes for hypertrophic cardiomyopathy using integrated network analysis of differential lncRNA and gene expression., PMID:35990977

Bone marrow transplantation as a therapy for autosomal dominant osteopetrosis type 2 in mice., PMID:35959867

Anterior cruciate ligament rupture in a patient with Albers-Schonberg disease., PMID:35902893

A Mild Case of Autosomal Recessive Osteopetrosis Masquerading as the Dominant Form Involving Homozygous Deep Intronic Variations in the CLCN7 Gene., PMID:35618777

Clinical and Genetic Features of Chinese Adult Patients With Chronic Non-Bacterial Osteomyelitis: A Single Center Report., PMID:35422809

Natural History of Type II Autosomal Dominant Osteopetrosis: A Single Center Retrospective Study., PMID:35370969

The FACT complex facilitates expression of lysosomal and antioxidant genes through binding to TFEB and TFE3., PMID:35230915

Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway., PMID:35228997

The Role of the Lysosomal Cl-/H+ Antiporter ClC-7 in Osteopetrosis and Neurodegeneration., PMID:35159175

Osteogenesis Imperfecta: Search for Mutations in Patients from the Republic of Bashkortostan (Russia)., PMID:35052464

Genetic analysis of osteopetrosis in Pakistani families identifies novel and known sequence variants., PMID:34753502

Clinical presentation and analysis of genotype-phenotype correlations in patients with malignant infantile osteopetrosis., PMID:34624559

Clinical and molecular characterization of five Chinese patients with autosomal recessive osteopetrosis., PMID:34545712

Chloroquine increases osteoclast activity in vitro but does not improve the osteopetrotic bone phenotype of ADO2 mice., PMID:34464779

Reelin depletion alleviates multiple myeloma bone disease by promoting osteogenesis and inhibiting osteolysis., PMID:34433809

CLCN7-related neuropathic infantile osteopetrosis in siblings., PMID:34258831

Efficient generation of osteoclasts from human induced pluripotent stem cells and functional investigations of lethal CLCN7-related osteopetrosis., PMID:33905594

Membrane Transport Proteins in Osteoclasts: The Ins and Outs., PMID:33718388

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CLCN7 Protein, N-His [YHE87201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only